KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Income from Continuing Operations (2016 - 2025)

AbbVie (ABBV) has disclosed Income from Continuing Operations for 14 consecutive years, with 1815000000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 7991.3% to 1815000000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 4233000000.0, a 1.24% decrease, with the full-year FY2025 number at 4233000000.0, down 1.24% from a year prior.
  • Income from Continuing Operations was 1815000000.0 for Q4 2025 at AbbVie, up from 188000000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 4493000000.0 in Q1 2022 to a low of 97000000.0 in Q1 2023.
  • A 5-year average of 1839300000.0 and a median of 1468500000.0 in 2024 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: skyrocketed 10544.74% in 2021, then tumbled 102.16% in 2023.
  • AbbVie's Income from Continuing Operations stood at 4045000000.0 in 2021, then tumbled by 38.89% to 2472000000.0 in 2022, then plummeted by 52.99% to 1162000000.0 in 2023, then tumbled by 101.98% to 23000000.0 in 2024, then soared by 7991.3% to 1815000000.0 in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Income from Continuing Operations are 1815000000.0 (Q4 2025), 188000000.0 (Q3 2025), and 941000000.0 (Q2 2025).